DK0693077T3 - Antivirusforbindelser - Google Patents

Antivirusforbindelser

Info

Publication number
DK0693077T3
DK0693077T3 DK94912709T DK94912709T DK0693077T3 DK 0693077 T3 DK0693077 T3 DK 0693077T3 DK 94912709 T DK94912709 T DK 94912709T DK 94912709 T DK94912709 T DK 94912709T DK 0693077 T3 DK0693077 T3 DK 0693077T3
Authority
DK
Denmark
Prior art keywords
pct
nucleoside analog
mono
sec
formula
Prior art date
Application number
DK94912709T
Other languages
Danish (da)
English (en)
Inventor
Kjell Torgeir Stokke
Bernt Borretzen
Are Dalen
Finn Myhren
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Application granted granted Critical
Publication of DK0693077T3 publication Critical patent/DK0693077T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
DK94912709T 1993-04-05 1994-04-05 Antivirusforbindelser DK0693077T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939307043A GB9307043D0 (en) 1993-04-05 1993-04-05 Chemical compounds
PCT/NO1994/000071 WO1994022887A1 (en) 1993-04-05 1994-04-05 New antiviral compounds

Publications (1)

Publication Number Publication Date
DK0693077T3 true DK0693077T3 (da) 1999-06-14

Family

ID=10733340

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94912709T DK0693077T3 (da) 1993-04-05 1994-04-05 Antivirusforbindelser

Country Status (21)

Country Link
US (1) US6153594A (ru)
EP (1) EP0693077B1 (ru)
JP (1) JP3049258B2 (ru)
KR (1) KR100309194B1 (ru)
AT (1) ATE171457T1 (ru)
AU (1) AU685104B2 (ru)
CA (1) CA2158853C (ru)
CZ (1) CZ287755B6 (ru)
DE (1) DE69413529T2 (ru)
DK (1) DK0693077T3 (ru)
ES (1) ES2124883T3 (ru)
FI (1) FI111370B (ru)
GB (1) GB9307043D0 (ru)
HK (1) HK1003437A1 (ru)
HU (1) HU228064B1 (ru)
NZ (1) NZ263888A (ru)
PL (1) PL177263B1 (ru)
RU (1) RU2139884C1 (ru)
SK (1) SK281231B6 (ru)
UA (1) UA41361C2 (ru)
WO (1) WO1994022887A1 (ru)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9515279D0 (en) 1995-07-25 1995-09-20 Norsk Hydro As Improved therapeutic agents
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
AU720451B2 (en) * 1997-01-24 2000-06-01 Conpharma As Gemcitabine derivatives
US5891881A (en) * 1997-11-21 1999-04-06 Clarion Pharmaceuticals Inc. Aminoheterocycle-substituted glycerols
EP1042341A1 (en) * 1997-11-25 2000-10-11 Protarga Inc. Nucleoside analog compositions and uses thereof
DE69935513T2 (de) 1998-07-09 2007-11-29 Sankyo Co., Ltd. Antibakterielle verbindungen
AU762395B2 (en) * 1998-10-16 2003-06-26 Schering Corporation Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
US6277830B1 (en) 1998-10-16 2001-08-21 Schering Corporation 5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon
US6403564B1 (en) 1998-10-16 2002-06-11 Schering Corporation Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
TWI245047B (en) 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
AU2001255495A1 (en) 2000-04-20 2001-11-07 Schering Corporation Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rnain patients having chronic hepatitis c infection
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
NZ547204A (en) * 2000-05-26 2008-01-31 Idenix Cayman Ltd Methods and compositions for treating flaviviruses and pestiviruses
AU2003222197A1 (en) * 2002-01-16 2003-09-02 The Regents Of The University Of California Inhibition of rna function
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7456155B2 (en) 2002-06-28 2008-11-25 Idenix Pharmaceuticals, Inc. 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
US20040077607A1 (en) * 2002-10-21 2004-04-22 Uckun Fatih M. Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses
JP2006504438A (ja) * 2002-11-01 2006-02-09 エヴォジェニクス・ピーティーワイ・リミテッド リバビリンおよび／またはｒｎａレプリカーゼを使用した変異誘発方法
HUE033832T2 (en) 2002-11-15 2018-01-29 Idenix Pharmaceuticals Llc 2'-methyl nucleosides in combination with interferon and Flaviviridae mutation
TWI332507B (en) 2002-11-19 2010-11-01 Hoffmann La Roche Antiviral nucleoside derivatives
PL377287A1 (pl) 2002-12-12 2006-01-23 Idenix (Cayman) Limited Sposób wytwarzania 2'-rozgałęzionych nukleozydów
EP1745573A4 (en) * 2003-03-20 2010-05-26 Microbiol Quimica Farmaceutica PROCESS FOR PREPARING 2-DEOXY-BETA-L-NUCLEOSIDES
US20070160554A1 (en) * 2003-11-03 2007-07-12 Cognis Ip Management Gmbh Acyl ribonucleosides and acyl deoxyribonucleosides, compositions of, and methods of making same
FR2874016B1 (fr) 2004-06-30 2006-11-24 Centre Nat Rech Scient Cnrse Nanoparticules de derives de la gemcitabine
US9029345B2 (en) * 2005-03-16 2015-05-12 Case Western Reserve University Selective inhibitors of translesion DNA replication
WO2006101911A1 (en) 2005-03-16 2006-09-28 Case Western Reserve University Selective inhibitors of translesion dna replication
NO324263B1 (no) * 2005-12-08 2007-09-17 Clavis Pharma Asa Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
CA2634749C (en) 2005-12-23 2014-08-19 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
US8497292B2 (en) 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
RU2488591C2 (ru) * 2007-09-26 2013-07-27 Маунт Синай Скул Оф Медсин Аналоги азацитидина и их применение
US9988680B2 (en) 2011-09-01 2018-06-05 Case Western Reserve University Non-natural nucleosides as theranostic agents
US9821173B2 (en) 2013-02-08 2017-11-21 Case Western Reserve University Anti-cancer agents and methods of use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920630A (en) * 1970-09-24 1975-11-18 Upjohn Co 2,2{40 -Anhydro-ara-cytidine compounds and process of preparation
GB1325797A (en) * 1970-09-24 1973-08-08 Upjohn Co Medicines comprising cytidine derivatives
US3984396A (en) * 1971-06-01 1976-10-05 Icn Pharmaceuticals, Inc. 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
US3998807A (en) * 1972-03-03 1976-12-21 Syntex (U.S.A.) Inc. Arabinofuranosyl cytosines and methods of making
GB1482736A (en) * 1974-03-18 1977-08-10 Icn Pharmaceuticals 1-(beta-d-ribofuranosyl)-1,2,4-triazole acid derivatives
US3960836A (en) * 1974-07-22 1976-06-01 Eli Lilly And Company Acylated derivatives of pyrazofurin and process for their preparation
JPS5159880A (en) * 1974-11-22 1976-05-25 Asahi Chemical Ind N44 ashirunukureoshidojikarubonsanesuteruno seiho
DE3100478A1 (de) * 1981-01-09 1982-08-12 Dr. Thilo & Co GmbH, 8021 Sauerlach 5'ester von pyrimidinnucleosiden mit antiviraler wirksamkeit, verfahren zur herstellung und daraus hergestellte arzneimittel
US4531001A (en) * 1982-03-23 1985-07-23 Brigham Young University 2-β-D-ribofuranosylselenazole-4-carboxamide compounds
JPH0655755B2 (ja) * 1985-01-23 1994-07-27 富山化学工業株式会社 新規な５−フルオロ−２′−デオキシウリジン−３′−ホスフエ−ト誘導体およびその塩
US4684631A (en) * 1984-10-09 1987-08-04 Toyama Chemical Co., Ltd. Novel 5-fluoro-2-deoxyuridine derivatives and salts thereof, process for producing the same, and antitumor agents containing the same
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
JPS6483092A (en) * 1987-09-24 1989-03-28 Arakawa Chotaro & Co Novel n6,n6-dimethyladenosine derivative having carcinostatic activity, its production and carcinostatic agent containing said derivative as active component
JPH0278696A (ja) * 1988-09-13 1990-03-19 Shoichiro Ozaki ５−フルオロウラシル誘導体
IE980216A1 (en) * 1989-04-17 2000-02-23 Scotia Holdings Plc Anti-virals
GB2260319B (en) * 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
US5405837A (en) * 1993-05-18 1995-04-11 Indiana University Foundation Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin

Also Published As

Publication number Publication date
EP0693077B1 (en) 1998-09-23
FI111370B (fi) 2003-07-15
EP0693077A1 (en) 1996-01-24
PL310970A1 (en) 1996-01-22
PL177263B1 (pl) 1999-10-29
AU6514194A (en) 1994-10-24
GB9307043D0 (en) 1993-05-26
ATE171457T1 (de) 1998-10-15
WO1994022887A1 (en) 1994-10-13
CA2158853A1 (en) 1994-10-13
DE69413529T2 (de) 1999-04-29
HU9502896D0 (en) 1995-11-28
CA2158853C (en) 1999-07-27
SK123395A3 (en) 1996-04-03
ES2124883T3 (es) 1999-02-16
HU228064B1 (en) 2012-09-28
SK281231B6 (sk) 2001-01-18
CZ259395A3 (en) 1996-06-12
KR100309194B1 (ko) 2002-06-20
FI954727A (fi) 1995-10-04
HUT73659A (en) 1996-09-30
UA41361C2 (ru) 2001-09-17
RU2139884C1 (ru) 1999-10-20
HK1003437A1 (en) 1998-10-30
JPH08508477A (ja) 1996-09-10
NZ263888A (en) 1998-05-27
US6153594A (en) 2000-11-28
CZ287755B6 (en) 2001-01-17
FI954727A0 (fi) 1995-10-04
DE69413529D1 (de) 1998-10-29
AU685104B2 (en) 1998-01-15
JP3049258B2 (ja) 2000-06-05

Similar Documents

Publication Publication Date Title
DK0693077T3 (da) Antivirusforbindelser
YU89792A (sh) O-heteroaril, o-alkilheteroaril, o-alkenil-heteroaril i o-alkinilheteroaril makrolidi, o-h
ES2183023T3 (es) Composicion farmaceutica estabilizada con un agente basico.
ES2134926T3 (es) Derivados vinileno-azaindolicos y su procedimiento de preparacion.
ITMI922699A1 (it) Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
ES2111615T3 (es) Imidazolidil macrolidos con actividad inmunosupresora.
DK0917540T3 (da) Termoplastisk forarbejdelige stivelses- eller stivelsesderivatpolymerblandinger
AR246527A1 (es) Procedimiento para la preparacion de n-acil-n,n'-di-lisogangliosidos, n'-acil-n,n'-di-lisogangliosidos y n,n'-diacil-n,n'-di-lisogangliosidos.
ATE16488T1 (de) M-4- und isom-4-derivate, ihre herstellung und diese enthaltende zusammensetzungen.
EP0536402A4 (en) Piperidine derivative
ES2117976T3 (es) Preparacion de derivados n-acetil neuraminicos.
NO974266D0 (no) 10-deacetylbaccatin III- og 10-deacetyl-14<beta>-hydroksybaccatin III-derivater, fremgangsmåte ved deres fremstilling og farmasöytiske blandinger som inneholder dem
ES2161759T3 (es) Derivados de profarmacos de inhibidores de enzimas con grupos hidroxilo, procedimiento para su preparacion y su utilizacion.
KR0140401B1 (en) Anti-bloom triglyceride compositions
ES466037A1 (es) Un procedimiento para preparar derivados de oleandomicina.
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
DE69028320D1 (de) Illudin-analoge, verwendet als antitumormittel
ES2164869T3 (es) Conjugados lipidos especificos de nucleosidos-difosfato y su uso como medicamentos.
ES8609482A1 (es) Un metodo para producir acido dihidrodesoxigriseolico y sa- les y esteres del mismo
BR9707342A (pt) Dihidrobensofurano e compostos correlatod úteis como agentes antiinflamatórios
DE69120670D1 (de) Lipo-oligosaccharide als pflanzenspezifisches regulierendes mittel, verfahren zu ihrer herstellung und ihre verwendungen
ES2074264T3 (es) Esteres de aminoacidos de la hidroquinona, su procedimiento de preparacion y composiciones farmaceuticas o cosmeticas que los contienen.
HUP0002712A2 (hu) Daganat elleni hatású makrolidok
FI903754A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara lysogangliosidderivat.
ES476542A1 (es) Un procedimiento para la preparacion de nuevos derivados de oleandomicina